Drug · DIN 02418363
AZITHROMYCIN
No: cancelled before it was sold
Authorized, then cancelled before it was ever sold in Canada.
Status Cancelled Pre Market since June 17, 2019.
- Drug Identification Number (DIN)
- 02418363
- Company (DIN owner)
- Dominion PharmacalMontreal, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Powder For Suspension
- Route
- Oral
- Therapeutic class (ATC)
- Azithromycin J01FA10
- Class
- Human
- Record last updated
- June 23, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| AZITHROMYCIN | 100 MG | 5 ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- January 15, 2014: NOC 15124New Drug Submission (NDS) · Licensing agreement between two companies
Other DINs named AZITHROMYCIN
- DIN 02330881 · Marketed
- DIN 02442434 · Marketed
- DIN 02545969 · Marketed
- DIN 02274388 · Cancelled Post Market
- DIN 02274396 · Cancelled Post Market
- DIN 02330911 · Cancelled Post Market
- DIN 02342030 · Cancelled (Unreturned Annual)
- DIN 02342049 · Cancelled (Unreturned Annual)
- DIN 02343347 · Cancelled Pre Market
- DIN 02343355 · Cancelled Pre Market
- DIN 02418371 · Cancelled Pre Market
- DIN 02477629 · Cancelled Pre Market
- DIN 02545977 · Approved